Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Turnstone Biologics Corp. Common Stock

TSBX
Current price
0.5 USD +0.04 USD (+8.73%)
Last closed 0.47 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 846 418 USD
Yield for 12 month -84.53 %
1Y
3Y
5Y
10Y
15Y
TSBX
21.11.2021 - 28.11.2021

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California. Address: 9310 Athena Circle, La Jolla, CA, United States, 92037

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.42 USD

P/E ratio

Dividend Yield

Current Year

+19 306 000 USD

Last Year

+73 300 000 USD

Current Quarter

Last Quarter

Current Year

+16 506 000 USD

Last Year

+71 100 000 USD

Current Quarter

-500 000 USD

Last Quarter

-509 000 USD

Key Figures TSBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -77 827 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -66.1 %
PEG Ratio
Return On Equity TTM -134.46 %
Wall Street Target Price 2.42 USD
Revenue TTM
Book Value 2.58 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 71 133 000 USD
Earnings per share -3.23 USD
Diluted Eps TTM -3.23 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TSBX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TSBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation TSBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 2.1344
Enterprise Value EBITDA 0.7977
Price Book MRQ 0.1983

Financials TSBX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TSBX

For 52 weeks

0.44 USD 5.75 USD
50 Day MA 0.6 USD
Shares Short Prior Month 497 466
200 Day MA 2.22 USD
Short Ratio 2.82
Shares Short 387 819
Short Percent 3.62 %